Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and

Yogatheesan Varatharajah1, Vijay K Ramanan2, Ravishankar Iyer3

  • 1Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. varatha2@illinois.edu.

Scientific Reports
|February 21, 2019
PubMed

Insights

Predicting Alzheimer's disease progression in mild cognitive impairment (MCI) is now more accurate (~93%) using advanced machine learning models. These models integrate neuroimaging, biomarkers, and genetics to identify at-risk individuals early.

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Genetics

Background:

  • Mild cognitive impairment (MCI) is a prodromal stage of Alzheimer's disease (AD).
  • Early identification of MCI individuals progressing to AD dementia is crucial for timely clinical management.
  • Integrating diverse patient data offers potential for improved predictive accuracy.

Purpose of the Study:

  • To develop generalizable multivariate models for identifying MCI individuals who will progress to AD dementia within three years.
  • To integrate high-dimensional data, including neuroimaging, cerebrospinal fluid biomarkers, genetic factors, and cognitive resilience measures.
  • To assess the predictive value of specific AD pathophysiology markers and genetic factors.

Main Methods:

  • Development of multivariate models using machine learning techniques.
  • Integration of multimodal patient data: neuroimaging, CSF biomarkers, genetic data, and cognitive resilience.
  • Validation of model generalizability and accuracy in predicting progression to AD dementia.

Main Results:

  • Achieved clinically relevant accuracy (~93%) in identifying MCI to AD progression within three years.
  • AD pathophysiology markers (amyloid, tau, neuronal injury) significantly contributed to prediction.
  • Complement receptor 1 (CR1) gene expression provided unique, independent predictive value.

Conclusions:

  • Optimized machine learning approaches effectively analyze multimodal patient data for predictive assessments in the AD continuum.
  • Multimodal data integration, including genetic factors like CR1, enhances the prediction of Alzheimer's disease progression.
  • Accurate prediction of MCI progression supports early intervention strategies for Alzheimer's disease.

Related Concept Videos

Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.7K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K